Almirall
-
Glenmark’s subsidiary Ichnos Sciences in licensing agreement with Almirall
Almirall is granted exclusive global rights to develop and commercialise ISB 880 for use in autoimmune diseases Ichnos Sciences, a…
Read More »
Almirall is granted exclusive global rights to develop and commercialise ISB 880 for use in autoimmune diseases Ichnos Sciences, a…
Read More »